Skip to content

Mirtazapine (MTZ) Rapid Test Device-Urine

by Rapid Labs Ltd EUDAMED

Active European Union

Ref D-DOA78D40

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-D-DOA78D40EZ Basic UDI-DIDate28 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Model / Reference
D-DOA78D40
Primary DI / UDI-DI
D-D-DOA78D40EZ
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
GB-MF-000026335
Authorised representative
VidaQuick Biotech S.L. ES-AR-000048138

Other devices from Rapid Labs Ltd

See all devices from Rapid Labs Ltd →